Blood cancers

Studies highlight burden of COVID-19 on people with blood disorders

Several studies presented at the ASH 21 meeting shed further light on the impact of COVID-19 on people with blood disorders, and advanced understanding of the related risk of serious illness or death, treatment and the efficacy of vaccination in these potentially vulnerable patient populations.    A key analysis of more than 1,000 patients in ...

Already a member?

Login to keep reading.

© 2022 the limbic